Keros Therapeutics, Inc. (KROS)
NASDAQ: KROS · Real-Time Price · USD
13.57
+0.10 (0.78%)
At close: Jun 18, 2025, 4:00 PM
13.55
-0.01 (-0.11%)
After-hours: Jun 18, 2025, 7:06 PM EDT
Keros Therapeutics Employees
Keros Therapeutics had 169 employees as of December 31, 2024. The number of employees increased by 33 or 24.26% compared to the previous year.
Employees
169
Change (1Y)
33
Growth (1Y)
24.26%
Revenue / Employee
$1,270,491
Profits / Employee
$24,923
Market Cap
550.34M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 94,300 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
| AbbVie | 55,000 |
KROS News
- 10 days ago - ADAR1 Issues Statement on Keros Therapeutics' Troubling 2025 Director Election Results and Insufficient Capital Return Proposal - PRNewsWire
- 10 days ago - Keros Announces Return of $375 Million in Excess Capital to Stockholders - GlobeNewsWire
- 12 days ago - Keros Therapeutics Announces Participation at Goldman Sachs 46th Annual Global Healthcare Conference - GlobeNewsWire
- 21 days ago - Keros Therapeutics Announces TROPOS Topline Data and Corporate Restructuring - GlobeNewsWire
- 23 days ago - Leading Independent Proxy Advisory Firm Glass Lewis Recommends Stockholders Vote “FOR” All of Keros' Director Nominees - GlobeNewsWire
- 4 weeks ago - ADAR1 Announces ISS Recommends Keros Therapeutics Stockholders WITHHOLD Votes from Directors Dr. Mary Ann Gray and Dr. Alpna Seth - PRNewsWire
- 5 weeks ago - ADAR1 Capital Management Releases Investor Presentation Outlining Its Rationale for Withholding Votes From Directors Dr. Mary Ann Gray and Dr. Alpna Seth - PRNewsWire
- 5 weeks ago - Keros Therapeutics Announces Participation at Bank of America 2025 Global Healthcare Conference - GlobeNewsWire